5beta-Cholanoic acid

5beta-cholanoic acid is a lipid of Sterol Lipids (ST) class. The involved functions are known as Vasodilation and Intestinal Absorption. The associated genes with 5beta-Cholanoic acid are iberiotoxin.

Cross Reference

Introduction

To understand associated biological information of 5beta-Cholanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 5beta-Cholanoic acid?

There are no associated biomedical information in the current reference collection.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with 5beta-Cholanoic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 5beta-Cholanoic acid?

There are no associated biomedical information in the current reference collection.

What functions are associated with 5beta-Cholanoic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 5beta-Cholanoic acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with 5beta-Cholanoic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 5beta-Cholanoic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 5beta-Cholanoic acid

Download all related citations
Per page 10 20 50 100 | Total 70
Authors Title Published Journal PubMed Link
Yealland G et al. Rescue of mitochondrial function in parkin-mutant fibroblasts using drug loaded PMPC-PDPA polymersomes and tubular polymersomes. 2016 Neurosci. Lett. pmid:27412236
Renga B et al. Cystathionine γ-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids. 2015 Am. J. Physiol. Heart Circ. Physiol. pmid:25934094
Jung JI et al. Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator. 2015 Mol Neurodegener pmid:26169917
Luengo-Alonso C et al. A novel performing PEG-cholane nanoformulation for Amphotericin B delivery. 2015 Int J Pharm pmid:26319629
Coufalová L et al. New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers. 2013 Steroids pmid:23435200
Mrózek L et al. New polyfluorothiopropanoyloxy derivatives of 5β-cholan-24-oic acid designed as drug absorption modifiers. 2013 Steroids pmid:23707574
Russo S et al. Synthesis and structure-activity relationships of amino acid conjugates of cholanic acid as antagonists of the EphA2 receptor. 2013 Molecules pmid:24152675
Mortiboys H et al. Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson's disease. 2013 Brain pmid:24000005
Na JH et al. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency. 2012 J Control Release pmid:22846988
Tognolini M et al. Structure-activity relationships and mechanism of action of Eph-ephrin antagonists: interaction of cholanic acid with the EphA2 receptor. 2012 ChemMedChem pmid:22529030